Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$26.12 - $34.07 $130,417 - $170,111
4,993 Added 3.94%
131,695 $4.49 Million
Q1 2024

May 13, 2024

BUY
$26.64 - $40.31 $8,258 - $12,496
310 Added 0.25%
126,702 $4.46 Million
Q4 2023

Feb 14, 2024

BUY
$19.95 - $31.0 $285,145 - $443,083
14,293 Added 12.75%
126,392 $3.65 Million
Q3 2023

Nov 14, 2023

SELL
$21.33 - $59.42 $2.22 Million - $6.19 Million
-104,098 Reduced 48.15%
112,099 $2.57 Million
Q2 2023

Aug 14, 2023

SELL
$34.33 - $62.11 $3.67 Million - $6.64 Million
-106,964 Reduced 33.1%
216,197 $12.4 Million
Q1 2023

May 15, 2023

SELL
$26.01 - $48.69 $381,696 - $714,525
-14,675 Reduced 4.34%
323,161 $12.2 Million
Q4 2022

Feb 14, 2023

BUY
$24.14 - $30.37 $2.5 Million - $3.14 Million
103,430 Added 44.12%
337,836 $9.04 Million
Q3 2022

Nov 14, 2022

BUY
$22.23 - $33.37 $3.51 Million - $5.27 Million
158,042 Added 206.96%
234,406 $6.63 Million
Q2 2022

Aug 15, 2022

BUY
$19.74 - $43.01 $190,372 - $414,788
9,644 Added 14.45%
76,364 $1.66 Million
Q1 2022

May 16, 2022

SELL
$36.25 - $52.02 $20,445 - $29,339
-564 Reduced 0.84%
66,720 $2.87 Million
Q4 2021

Feb 14, 2022

SELL
$43.27 - $65.72 $239,542 - $363,825
-5,536 Reduced 7.6%
67,284 $2.92 Million
Q3 2021

Nov 12, 2021

SELL
$53.61 - $67.5 $2.54 Million - $3.2 Million
-47,472 Reduced 39.46%
72,820 $4.92 Million
Q2 2021

Aug 16, 2021

BUY
$45.13 - $64.99 $2.34 Million - $3.37 Million
51,844 Added 75.74%
120,292 $6.9 Million
Q1 2021

May 17, 2021

BUY
$29.77 - $84.85 $291,537 - $830,936
9,793 Added 16.7%
68,448 $2.48 Million
Q4 2020

Feb 16, 2021

BUY
$25.66 - $34.55 $113,648 - $153,021
4,429 Added 8.17%
58,655 $1.97 Million
Q3 2020

Nov 16, 2020

BUY
$22.51 - $30.11 $40,608 - $54,318
1,804 Added 3.44%
54,226 $1.48 Million
Q2 2020

Aug 14, 2020

SELL
$12.65 - $29.57 $302,056 - $706,072
-23,878 Reduced 31.29%
52,422 $1.42 Million
Q1 2020

May 14, 2020

BUY
$10.84 - $20.85 $827,092 - $1.59 Million
76,300 New
76,300 $1.12 Million

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.